Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Lonza Group AG
  6. News
  7. Summary
    LONN   CH0013841017

LONZA GROUP AG

(LONN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Lonza : Intron Health Lowers Price Target on Lonza Group, Maintains Hold Recommendation

10/13/2021 | 06:48am EST


ę MT Newswires 2021
All news about LONZA GROUP AG
12/02Leucid Bio and Lonza Enter Strategic Collaboration to Leverage the Cocoon? Platform for..
CI
11/30Lonza Teams Up with Bioqube Ventures on Potential Biologics, Small Molecules Developmen..
MT
11/30LONZA : and Bioqube Ventures Sign a Framework Agreement for the Future Development and Man..
PU
11/29Oxford BioMedica, Lonza, Fujifilm Eye UK's Vaccine Manufacturing Innovation Center
MT
11/17Lonza Agrees to Manufacture Bluejay's Lead Antibody Candidate For Chronic Hepatitis B V..
MT
11/17GLOBAL MARKETS LIVE : Tesla, Experian, Roche, Activision, Amazon...
AX
11/17LONZA : and BlueJay Therapeutics Announce Manufacturing Agreement for its Antibody BJT-778..
PU
11/16Lonza to Boost Microbial Development Lab Capabilities at Swiss Site
MT
11/16LONZA : to Expand Microbial Development Laboratories
PU
11/10Lonza JV Bacthera, Seres to Jointly Produce Potential Gut Infection Treatment
MT
More news
Analyst Recommendations on LONZA GROUP AG
More recommendations
Financials
Sales 2021 5 174 M 5 636 M 5 636 M
Net income 2021 720 M 784 M 784 M
Net cash 2021 569 M 620 M 620 M
P/E ratio 2021 69,8x
Yield 2021 0,43%
Capitalization 53 365 M 58 058 M 58 132 M
EV / Sales 2021 10,2x
EV / Sales 2022 8,99x
Nbr of Employees 14 405
Free-Float 99,7%
Chart LONZA GROUP AG
Duration : Period :
Lonza Group AG Technical Analysis Chart | LONN | CH0013841017 | MarketScreener
Technical analysis trends LONZA GROUP AG
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 718,40 CHF
Average target price 781,49 CHF
Spread / Average Target 8,78%
EPS Revisions
Managers and Directors
Pierre-Alain Ruffieux Chief Executive Officer
Rodolfo Savitzky Chief Financial Officer
Albert M. Baehny Chairman
Werner J. Bauer Independent Director
Barbara May Richmond No-Executive Independent Director
Sector and Competitors
1st jan.Capi. (M$)
LONZA GROUP AG25.98%57 878
MODERNA, INC.188.59%122 239
IQVIA HOLDINGS INC.46.64%50 192
SEAGEN INC.-9.40%29 014
CELLTRION, INC.-41.36%24 745
ICON PUBLIC LIMITED COMPANY40.04%22 226